Pharmaceutical

The fundamentals of developing parenteral drug products 

Advancing to first-in-human clinical trials requires formulation development to design a successful sterile formulation that meets your TPP.

Nov 9, 2024 - 06:00
The fundamentals of developing parenteral drug products 
Advancing to first-in-human clinical trials requires formulation development to design a successful sterile formulation that meets your TPP.
Read the original article

Tags:

Previous Article

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

Next Article

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs

STAT+: Pharmalittle: Drugmakers agree to negotiate Medi...

Oct 4, 2023

NHS proposes phased launch for Eli Lilly’s Mounjaro

NHS proposes phased launch for Eli Lilly’s Mounjaro

Oct 6, 2024

Cara Therapeutics cuts 50% of staff and drops kidney disease program

Cara Therapeutics cuts 50% of staff and drops kidney di...

Jan 23, 2024